GERALD Y. HO M.D. NPI 1205833662

NPI Details

Gerald Y. Ho, M.D. is a rheumatology internal medicine in La Palma, CA with 38 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Gerald Y. Ho, M.D. NPI is 1205833662. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

5451 LA PALMA AVE
SUITE 25
LA PALMA, CA
ZIP 90623-730
Phone: (714) 670-1340
Fax: (714) 443-3780

The NPI 1205833662 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, belimumab, 10 mg (HCPCS:J0490)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg (HCPCS:J7332)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Methotrexate sodium, 5 mg (HCPCS:J9250)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• X-ray of hand, 2 views (HCPCS:73120)
• X-ray of foot, 2 views (HCPCS:73620)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose (HCPCS:J7324)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Injection, orphenadrine citrate, up to 60 mg (HCPCS:J2360)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• X-ray of joint between lower spine and hip bone, 1-2 views (HCPCS:72200)
• X-ray of knee, 3 views (HCPCS:73562)
• X-ray of ankle, 2 views (HCPCS:73600)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Fine needle aspiration biopsy using ultrasound guidance, first growth (HCPCS:10005)
• X-ray of chest, 2 views (HCPCS:71046)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)

The enumeration date for this NPI number is 6/30/2005 and was last updated on 12/4/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.